How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

The new major version with a new JIT compiler, a revised parallelization API, and a maturing type system paves the way for ...

It uses use-tree-state hook internally for convenient state management.

Get Options quotes for Ginkgo Bioworks Holdings, Inc. (DNA). Calls and Puts. Strike price, bid, ask, volume, open interest. In the money.